Blindness: Clinical Trials

8 trials for Blindness, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

8 completed. 8 Phase 1, 6 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 18Completed 8
Phase 26Completed 6

Follow Blindness: new trials by email Literature Review of Blindness trials Research Report on Blindness

Trials (filtered) newest first · largest first

All 8 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety and Efficacy of NPI-001 Tablets for RP Associated With Usher Syndrome
NPI-001, Placebo - Usher Syndromes
Phase 1 / Phase 2CompletedNacuity Pharmaceuticals, Inc.492020-09-032026-07-01
Study to Evaluate Safety and Tolerability of QR-421a in Subjects With RP Due to Mutations in Exon 13 of the USH2A Gene
QR-421a, Sham-procedure (dose cohort 1&2 only) - Retinitis Pigmentosa, Usher Syndrome Type 2
Phase 1 / Phase 2CompletedProQR Therapeutics202019-03-062022-04-20
ADVM-022 Intravitreal Gene Therapy for Wet AMD
ADVM-022 - Wet Age-related Macular Degeneration, Neovascular Age-related Macular Degeneration
Phase 1CompletedAdverum Biotechnologies, Inc.302018-11-142023-08-08
A Clinical Trial of Dantrolene Sodium in Pediatric and Adult Patients With Wolfram Syndrome
dantrolene sodium - Wolfram Syndrome, Diabetes Mellitus
Phase 1 / Phase 2CompletedWashington University School of Medicine212017-01-012024-03-13
Combined tDCS and Vision Restoration Training in Post-acute Stroke: an Exploratory Efficacy and Safety Study
verum tDCS, sham tDCS, VRT - Hemianopia, Stroke
Phase 1 / Phase 2CompletedUniversity of Magdeburg192013-03-012016-03-09
Combined tDCS and Vision Restoration Training in Subacute Stroke Rehabilitation: A Pilot Study
tDCS, Standard rehabilitation - Hemianopia, Stroke
Phase 1 / Phase 2CompletedUniversity of Magdeburg142013-01-012016-10-17
Computer Vision System for the Blind Veteran
initial system, modified system - Blindness
Phase 1CompletedVA Office of Research and Development162011-11-012016-01-22
Clinical Trial Evaluating Rituximab in Ocular Cicatricial Pemphigoid
Rituximab - Ocular Cicatricial Pemphigoid
Phase 1 / Phase 2CompletedUniversity of Alabama at Birmingham32006-01-012026-05-04

Narrower conditions

Eye Diseases (2)  ·  Hemianopsia (2)  ·  Retinal Diseases (2)  ·  Stroke (2)  ·  Usher Syndromes (2)  ·  Ataxia (1)  ·  Diabetes Mellitus (1)  ·  Eye Abnormalities (1)  ·  Eye Diseases, Hereditary (1)  ·  Macular Degeneration (1)  ·  Optic Atrophy (1)  ·  Pemphigoid, Benign Mucous Membrane (1)  ·  Pemphigoid, Bullous (1)  ·  Retinal Degeneration (1)

Broader conditions

Nervous System Diseases (8)  ·  Neurologic Manifestations (8)  ·  Pathological Conditions, Signs and Symptoms (8)  ·  Sensation Disorders (8)  ·  Signs and Symptoms (8)  ·  Vision Disorders (7)  ·  Eye Diseases (6)  ·  Abnormalities, Multiple (3)  ·  Congenital Abnormalities (3)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (3)  ·  Deaf-Blind Disorders (3)  ·  Deafness (3)  ·  Ear Diseases (3)  ·  Eye Diseases, Hereditary (3)

Interventions

Dantrolene (1)  ·  Intravitreal Injections (1)  ·  Rituximab (1)  ·  Transcranial Direct Current Stimulation (1)

Sponsors

University of Magdeburg (2)  ·  Adverum Biotechnologies, Inc. (1)  ·  Nacuity Pharmaceuticals, Inc. (1)  ·  ProQR Therapeutics (1)  ·  University of Alabama at Birmingham (1)  ·  VA Office of Research and Development (1)  ·  Washington University School of Medicine (1)

Countries

United States (5)  ·  Austria (2)  ·  Germany (2)  ·  Australia (1)  ·  Canada (1)  ·  France (1)

Top investigators

Bernhard A Sabel, Prof. Dr. (1)  ·  Cha-Min Tang, PhD MD (1)  ·  Craig A Elmets (1)  ·  Fumihiko Urano, MD (1)  ·  Lee Anderson, MD (1)  ·  Raimund Alber, MS (1)

Results publications

PMID 28082176, PMID 31215818, PMID 34185708, PMID 37418643, PMID 38152412

NIH funding

2018 (1), R21DK113487 (1)